Sage Therapeutic News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sage therapeutic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sage Therapeutic Today - Breaking & Trending Today

Comparing PepGen (NASDAQ:PEPG) and Sage Therapeutics (NASDAQ:SAGE)

PepGen (NASDAQ:PEPG – Get Free Report) and Sage Therapeutics (NASDAQ:SAGE – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, valuation, profitability, risk and dividends. Earnings & Valuation This table compares PepGen and […] ....

United States , United Kingdom , South Korea , Pepgen Inc , Sterogen Biopharma Inc , Biogen Ma Inc , Shionogi Co Ltd , Sage Therapeutics Inc , Get Free Report , Sage Therapeutics , Sage Therapeutic , Given Sage Therapeutic , Amgen Inc , Sterogen Biopharma , Pepgen Daily ,

Q2 2024 EPS Estimates for Sage Therapeutics, Inc. Lifted by Analyst (NASDAQ:SAGE)

Sage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) – Wedbush upped their Q2 2024 earnings estimates for Sage Therapeutics in a note issued to investors on Thursday, April 25th. Wedbush analyst L. Chico now anticipates that the biopharmaceutical company will post earnings of ($1.83) per share for the quarter, up from their prior forecast of ($2.00). […] ....

New Zealand General , New Zealand , Jacobs Levy Equity Management Inc , Wellington Management Group , Morgan Stanley , Rafferty Asset Management , Sage Therapeutics Inc , Sage Therapeutics , Free Report , Sage Therapeutic , Get Free Report , Therapeutics Trading Down , Levy Equity Management , Asset Management , Bay Capital Management , Management Group , Sage Therapeutics Daily ,

Q1 2024 Earnings Estimate for Sage Therapeutics, Inc. (NASDAQ:SAGE) Issued By Wedbush

Sage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) – Wedbush decreased their Q1 2024 earnings per share estimates for shares of Sage Therapeutics in a report released on Wednesday, April 17th. Wedbush analyst L. Chico now forecasts that the biopharmaceutical company will earn ($1.92) per share for the quarter, down from their previous estimate of ($1.89). […] ....

Needham Company , Tower Research Capital , Sage Therapeutics Inc , China Universal Asset Management Co , Metlife Investment Management , Jpmorgan Chase Co , Sage Therapeutics , Free Report , Sage Therapeutic , Get Free Report , Universal Asset Management , Life Investment Management , Research Capital , Sage Therapeutics Daily , Nasdaq Sage , Earnings Estimates ,

Q1 2024 Earnings Forecast for Sage Therapeutics, Inc. Issued By Wedbush (NASDAQ:SAGE)

Sage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) – Stock analysts at Wedbush dropped their Q1 2024 earnings estimates for shares of Sage Therapeutics in a research note issued on Wednesday, April 17th. Wedbush analyst L. Chico now expects that the biopharmaceutical company will post earnings of ($1.92) per share for the quarter, down from their […] ....

Healthcare Of Ontario Pension Plan Trust Fund , Vanguard Group Inc , Fisher Asset Management , Needham Company , Hennion Walsh Asset Management Inc , Morgan Stanley , Royal Bank , Sage Therapeutics Inc , Goldman Sachs Group Inc , Sage Therapeutics , Free Report , Sage Therapeutic , Get Free Report , Walsh Asset Management , Ontario Pension Plan Trust Fund , Asset Management , Goldman Sachs Group , Sachs Group , Sage Therapeutics Daily , Nasdaq Sage , Earnings Estimates ,

PureTech launches Seaport, hoping to create Karuna 2.0

BioPharma ....

Daphne Zohar , Robert Nelsen , Eric Elenko , Bharatt Chowrira , Courtney Wallace , Steven Paul , Bristol Myers , James Healy , Drug Administration , Puretech Health , Bristol Myers Squibb , Sofinnova Investments , Third Rock Ventures , Karuna Therapeutics , Wall Street , Sage Therapeutic , Third Rock , Seaport Therapeutics ,